Loading...
Loading...
PLSE| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 302.0K |
| Gross Profit | -302.0K |
| Operating Expense | 9,562.0K |
| Operating I/L | -9,562.0K |
| Other Income/Expense | -239.0K |
| Interest Income | 561.0K |
| Pretax | -9,801.0K |
| Income Tax Expense | 478.0K |
| Net Income/Loss | -10,279.0K |
Pulse Biosciences, Inc. operates as a bioelectric medicine company, offering the CellFX System. This platform delivers nano second duration pulses of electrical energy to clear targeted cells while sparing adjacent non-cellular tissue, using Nano-Pulse Stimulation technology. The system is tunable, software-enabled, and console-based, and is used to treat various medical conditions. The company generates revenue by selling the CellFX System and related services.
